Juan J Lozano
Overview
Explore the profile of Juan J Lozano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cervera-Seco L, Baldan-Martin M, Fernandez-Tome S, Ortega Moreno L, Lozano J, Aransay A, et al.
Inflamm Bowel Dis
. 2025 Mar;
PMID: 40067082
Background: MicroRNAs (miRNAs) play a key role in regulating gene expression in Crohn's disease (CD). Although several studies have identified miRNAs with biomarker potential, an exhaustive characterization of the miRNAome...
2.
Elgosbi M, Kurt A, Londono M, Caballero-Marcos A, Lim T, Lozano J, et al.
Liver Transpl
. 2024 Aug;
PMID: 39172015
Hypothermic oxygenated machine perfusion (HOPE) is an organ preservation strategy shown to reduce ischemia-reperfusion injury (IRI)-related complications following liver transplantation. In animal models, HOPE can also decrease alloimmune responses after...
3.
Cortes M, Brischetto A, Martinez-Campanario M, Ninfali C, Dominguez V, Fernandez S, et al.
Nat Commun
. 2023 Nov;
14(1):7471.
PMID: 37978290
Acute inflammation can either resolve through immunosuppression or persist, leading to chronic inflammation. These transitions are driven by distinct molecular and metabolic reprogramming of immune cells. The anti-diabetic drug Metformin...
4.
Baldan-Martin M, Rubin de Celix C, Orejudo M, Ortega Moreno L, Fernandez-Tome S, Soleto I, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958675
Biological therapies only benefit one-third of patients with Crohn's disease (CD). For this reason, a deeper understanding of the mechanisms by which biologics elicit their effect on intestinal mucosa is...
5.
Sanchez-Tillo E, Pedrosa L, Vila I, Chen Y, Gyorffy B, Sanchez-Moral L, et al.
JCI Insight
. 2023 Oct;
8(20.
PMID: 37870961
Despite being in the same pathway, mutations of KRAS and BRAF in colorectal carcinomas (CRCs) determine distinct progression courses. ZEB1 induces an epithelial-to-mesenchymal transition (EMT) and is associated with worse...
6.
Arbaizar-Rovirosa M, Gallizioli M, Lozano J, Sidorova J, Pedragosa J, Figuerola S, et al.
J Neuroinflammation
. 2023 Sep;
20(1):207.
PMID: 37691115
Vascular endothelial function is challenged during cerebral ischemia and reperfusion. The endothelial responses are involved in inflammatory leukocyte attraction, adhesion and infiltration, blood-brain barrier leakage, and angiogenesis. This study investigated...
7.
Aldars-Garcia L, Gil-Redondo R, Embade N, Riestra S, Rivero M, Gutierrez A, et al.
Inflamm Bowel Dis
. 2023 Aug;
30(2):167-182.
PMID: 37536268
Background And Aims: Inflammatory bowel disease (IBD) is a prevalent chronic noncurable disease associated with profound metabolic changes. The discovery of novel molecular indicators for unraveling IBD etiopathogenesis and the...
8.
Nicoara-Farcau O, Lozano J, Alonso C, Sidorova J, Villanueva C, Albillos A, et al.
Hepatology
. 2023 Feb;
77(6):2052-2062.
PMID: 36811400
Background And Aims: Patients with compensated cirrhosis with clinically significant portal hypertension (CSPH: HVPG > 10 mm Hg) have a high risk of decompensation. HVPG is, however, an invasive procedure...
9.
Argemi J, Latasa M, Atkinson S, Blokhin I, Massey V, Gue J, et al.
Nat Commun
. 2023 Feb;
14(1):757.
PMID: 36765087
No abstract available.
10.
Arbaizar-Rovirosa M, Pedragosa J, Lozano J, Casal C, Pol A, Gallizioli M, et al.
EMBO Mol Med
. 2022 Dec;
15(2):e17175.
PMID: 36541061
Microglial cells of the aged brain manifest signs of dysfunction that could contribute to the worse neurological outcome of stroke in the elderly. Treatment with colony-stimulating factor 1 receptor antagonists...